Announcements Trials
Browse Landscape

Phase

Phase 2 42Phase 1 21Phase 1/2 17Phase 3 7Phase NA 3Phase 4 1Phase 2/3 1

Status

Completed 37Active not recruiting 12Terminated 7Recruiting 7Unknown 2Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 2NIH 1NETWORK 1

Study Type

Interventional 7

Sponsor

Cancer Type

Plasma cell 5Genitourinary 2Other hematologic neoplasm 1

Conditions

Multiple Myeloma 5Prostatic Neoplasms 2Parkinson Disease 4, Autosomal Dominant Lewy Body 1Hematologic Neoplasms 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Calcium Dobesilate × Clear all
NCT04907227 2024-07-12

KEYNOTE-921

Merck Sharp & Dohme LLC

Phase 3 Terminated
81 enrolled 19 charts
Genitourinary

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT03151811 2024-01-30

OCEAN

Oncopeptides AB

Phase 3 Terminated
495 enrolled 15 charts
Plasma cell

Multiple Myeloma

NCT02516696 2023-06-05

BiRd vs Rd

Weill Medical College of Cornell University

Phase 3 Terminated
12 enrolled 19 charts
Plasma cell

Multiple Myeloma

NCT00024167 2016-03-22

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

M.D. Anderson Cancer Center

Phase 3 Terminated
265 enrolled 9 charts
Genitourinary

Prostatic Neoplasms

NCT00522392 2015-06-26

Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone

National Cancer Institute (NCI)

Phase 3 Terminated
48 enrolled 9 charts
Plasma cell

Multiple Myeloma

NCT00005834 2015-03-06

S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma

SWOG Cancer Research Network

Phase 3 Terminated
19 enrolled
Plasma cell

Multiple Myeloma

NCT00215943 2014-04-17

Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)

H. Lee Moffitt Cancer Center and Research Institute

Phase 3 Terminated
90 enrolled 10 charts
Other hematologic neoplasmPlasma cell

Multiple Myeloma, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡